HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin K skin care products under FDA investigation for drug-like claims -- attorney Hyman.

This article was originally published in The Rose Sheet

Executive Summary

VITAMIN K SKIN CARE PRODUCTS UNDER FDA INVESTIGATION as the agency looks into whether certain ingredients used in cosmetics, such as vitamins and essential oils, may have "active roles," according to attorney Paul Hyman of the Washington, D.C. firm Hyman, Phelps & McNamara. Speaking at the Active Ingredients for Cosmetics and Personal Care Products Conference July 29-30 in Philadelphia, Hyman said FDA is "looking very closely at claims being made for vitamin K" products as "wrinkle smoothers." Hyman is a former trial attorney in FDA's general counsel office.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004497

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel